Skip to main content
Advertisement
Advertisement

BLRX

BLRX logo

BioLineRX Ltd

2.43
USD
Sponsored
-0.05
-2.02%
Sep 22, 13:31 UTC -4
Closed
exchange

After-Market

2.44

0.00
+0.21%

BLRX Earnings Reports

Positive Surprise Ratio

No Data Available for BLRX

0%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

BioLineRX Ltd earnings per share and revenue

On Aug 31, 2026, BLRX reported earnings of -0.77 USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 290.00 thousand, compared to an expected --, with a --% difference. The market reacted with a +7.69% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
FAQ
For Q2 2026, BioLineRX Ltd reported EPS of -$0.77, missing estimates by --, and revenue of $290.00K, -- -- expectations.
The stock price moved up 7.69%, changed from $2.60 before the earnings release to $2.80 the day after.
The next earning report is scheduled for --.
Based on -- analysts, BioLineRX Ltd is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement